TKNO

Insider Trades

Name	Value	Action	Price	Last Price
Lowell MatthewChief Financial Officer $88k40k shares BuyMar 6, 2026 $2.19 $5.42
Gunstream StephenDirector, Officer: President And CEO $56k26k shares BuyMar 6, 2026 $2.15 $5.42
Demski Martha JDirector $41k8k shares SellJun 27, 2025 $5.06 $5.42

News

seekingalpha.comAlpha Teknova, Inc. (TKNO) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 8

globenewswire.comTeknova Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 6

globenewswire.comTeknova to Report First Quarter 2026 Financial Results on May 6, 2026globenewswire.comApr 22

Trade TKNO

About Alpha Teknova, Inc.

Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.

CEO: Stephen Gunstream
IPO Date: Jun 25, 2021

Market Data

Volume: 72.5K

Valuation

Market Cap: $284.2M

Financials

Financial statement snapshot is not available yet.

Events

EarningsAug 6

EPS est. -0.08333